🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Status
Recruiting
Location
Skåne University Hospital
Start Date
2023-10-26
Trial ID
NCT05900206
This randomized phase III trial studies docetaxel, carboplatin, trastuzumab...
Status
Completed
Location
Fairbanks Memorial Hospital
Start Date
2014-02-18
Trial ID
NCT02003209
The study is being conducted to assess the efficacy and safety of anthracyc...
Status
Unknown
Location
Breast Oncology, Tianjin Medical University Cancer Institute and Hospital
Start Date
2022-10-08
Trial ID
NCT05871918
Treatments Being Tested
This phase II study evaluates the efficacy and safety of a de-escalated neo...
Status
Active Not Recruiting
Location
P.A. Hertsen Moscow Oncology Research Institute
Start Date
2023-09-01
Trial ID
NCT07421141
Treatments Being Tested
This is a randomized phase II study to evaluate the pathological complete r...
Status
Recruiting
Location
The University of Kansas Cancer Center (KUCC)
Start Date
2025-11-14
Trial ID
NCT07220135
Treatments Being Tested
Locally advanced breast cancer (LABC) is defined as breast cancer (BC) larg...
Status
Unknown
Location
Samsung Medical Center
Start Date
2018-03-01
Trial ID
NCT04276337
Treatments Being Tested
This study was a phase III, multicenter, triple-blind, equivalency clinical...
Status
Completed
Location
Besat Clinic
Start Date
2018-08-11
Trial ID
NCT04957212
Treatments Being Tested
The main purpose of this research study is to find out if de-escalation of ...
Status
Withdrawn
Location
University of Rochester Medical Center
Start Date
2025-08-11
Trial ID
NCT04419181
Treatments Being Tested
This study is to explore the markers in early prediction of the efficacy of...
Status
Recruiting
Location
Shanghai Cancer Center, Fudan University
Start Date
2020-04-21
Trial ID
NCT04281641
Treatments Being Tested
Primary Objective: • Determination of pathologic complete response (pCR) r...
Status
Terminated
Location
Mount Sinai Beth Israel
Start Date
2019-01-24
Trial ID
NCT03329378